Mirae Asset Global ETFs Holdings
ACTU

Mirae Asset Global ETFs Holdings’s Actuate Therapeutics ACTU Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ACTU Stock Details ACTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.4K Buy
4,525
+102
+2% +$423 ﹤0.01% 3066
2025
Q4 		$27.1K Buy
4,423
+1,740
+65% +$12K ﹤0.01% 3023
2025
Q3 		$17.9K Sell
2,683
-506
-16% -$3.67K ﹤0.01% 3055
2025
Q2 		$19.5K Buy
+3,189
New +$27.9K ﹤0.01% 2965

Other funds holding ACTU

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ACTU Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Actuate Therapeutics (ACTU) stake by 2.3% in Q1 2026, buying an estimated $423 and bringing the position to 4,525 shares worth $12.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3066.

Mirae Asset Global ETFs Holdings first reported a position in ACTU in Q2 2025 and has held it in 4 quarters since. The position peaked at $27.1K in Q4 2025. 61 funds tracked by Wall St. Rank hold ACTU as of Q1 2026.

  • Mirae Asset Global ETFs Holdings held 4,525 shares of Actuate Therapeutics worth $12.4K as of Q1 2026.
  • Mirae Asset Global ETFs Holdings bought 102 Actuate Therapeutics shares in Q1 2026, an estimated $423.
  • Actuate Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #3066 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Actuate Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Mirae Asset Global ETFs Holdings's Actuate Therapeutics position peaked at $27.1K in Q4 2025.
  • 61 funds tracked by Wall St. Rank held Actuate Therapeutics as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.